source
- Celcuity's Revtorpyk receives FDA approval, but launch delay pushes stock lowerThe FDA announced approval of Celcuity’s oncology candidate Revtorpyk on Tuesday, marking the company’s first cancer drug clearance. Analysts had broadly expected the approval and had priced the s…
- Jasper Therapeutics secures $132 million and merges with Kira Pharmaceuticals to revive pipelineJasper Therapeutics, a cash‑strapped biotech, announced it completed an all‑stock acquisition of privately held immune‑drug developer Kira Pharmaceuticals. The merger is paired with a private stoc…